These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Seeger TF, Thal L, Gardner EL. Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029 [Abstract] [Full Text] [Related]
49. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677 [Abstract] [Full Text] [Related]
58. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841. Krisch I, Bole-Vunduk B, Pepelnak M, Lavric B, Ocvirk A, Budihna MV, Sket D. J Pharmacol Exp Ther; 1994 Oct; 271(1):343-52. PubMed ID: 7965734 [Abstract] [Full Text] [Related]
59. Discrimination of neuroleptics by means of their interaction with amfonelic acid: an attempt to characterize the test. Waldmeier PC, Huber H, Heinrich M, Stoecklin K. Biochem Pharmacol; 1985 Jan 01; 34(1):39-44. PubMed ID: 2857083 [Abstract] [Full Text] [Related]